Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cervical cancer that has been confirmed by a tissue sample and is at a specific stage of spread (Stage IB2 to IIA2 based on international staging guidelines).
- You are 18 years of age or older.
- You are in reasonably good general health and are able to carry out daily activities, either fully or with only minor limitations (confirm with trial site).
- You are able to understand what the study involves, are willing to take part, and can sign a consent form.
- You are willing and able to attend all required appointments, provide samples at set points during the study, and share relevant health information.
Who may not be able to join:
- You have or have had another type of cancer.
- You are unwilling or unable to follow the specific treatment plan set out by the trial, or you change your treatment before your disease gets worse.
- You are not able to commit to attending all the follow-up appointments required by the study.
- You are unable to have a CT scan or other required tests used to check how the treatment is working.
- You have an autoimmune disease (a condition where your immune system mistakenly attacks your own body).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: jing xue, The Affiliated Suzhou Hospital of Nanjing Medical University
Phone: (+86)13771734347
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-year DFS in ITT population (intent-to-treat population)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.